← Leaderboards
Melpo Christofidou-Solomidou
University Of Pennsylvania
$5,805,617
Attributed
$6,515,405
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2006–19$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$6,515,405 · 9
By mechanism
R01$2,234,810 · 1
P42$1,414,664 · 1
R21$1,127,960 · 3
RC1$1,000,000 · 1
R41$600,859 · 2
R03$137,112 · 1
Top collaborators
- Katie Reindl2 shared
- Beth A Winkelstein2 shared
- Thais Sielecki1 shared
- Thais Motria Sielecki1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Kelly L Jordan-Sciutto$26,892,677
- Angela Haczku$7,604,827
- Taewan John Kim$483,826
- Frank J. Rauscher$12,105,145
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesAntioxidantsMouse ModelReactive Oxygen SpeciesPropertyLungAnti-InflammatoryDietIn VitroFlaxLignansInflammationToxic EffectAnti-Inflammatory AgentsMalignant Neoplasm Of LungCellsGenerationsFlaxseed LignanDesignLung DiseasesChemopreventive AgentBasePathogenesisComplex
Grant awards (22)
Serum Inflammasome proteins: Novel biomarker panel for radiation biodosimetry$301,260
R41 · FY2019 · ES
Graft-protective properties of LGM2605 in Lung Transplantation$299,599
R41 · FY2018 · HL
Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases$249,711
P42 · FY2018 · ES · contact PI
Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases$283,038
P42 · FY2017 · ES · contact PI
Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases$288,664
P42 · FY2016 · ES · contact PI
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION$200,000
R21 · FY2016 · AT · contact PI
Piperlongumine as a Novel Radiosensitizer for Lung Cancer$167,149
R21 · FY2016 · CA
Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases$294,966
P42 · FY2015 · ES · contact PI
NOVEL SYNTHETIC SDG TO TREAT TRAUMA-INDUCED INFLAMMATION$240,000
R21 · FY2015 · AT · contact PI
Piperlongumine as a Novel Radiosensitizer for Lung Cancer$211,568
R21 · FY2015 · CA
Biomedical Project 5 - Chemoprevention of Asbestos-induced Lung Diseases$298,285
P42 · FY2014 · ES · contact PI
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)$67,512
R03 · FY2014 · CA · contact PI
Mesothelioma inhibition by secoisolariciresinol diglucoside (SDG)$69,600
R03 · FY2013 · CA · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$317,009
R01 · FY2012 · CA · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$250,000
R01 · FY2012 · CA · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$631,453
R01 · FY2011 · CA · contact PI
Mitigation of Radiation Pneumonopathy By Lignan Action$1,000,000
RC1 · FY2010 · AI · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$394,654
R01 · FY2010 · CA · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$319,654
R01 · FY2009 · CA · contact PI
Secoisolariciresinol Diglucoside (SDB) Protection in Radiation Pheumonopathy$322,040
R01 · FY2008 · CA · contact PI
Use of Curcumin and Flaxsseed in Radiation Pneumonopathy$136,893
R21 · FY2007 · CA · contact PI
Use of Curcumin and Flaxsseed in Radiation Pneumonopathy$172,350
R21 · FY2006 · CA · contact PI